Nonalcoholic steatohepatitis

Mayo Clinic Proceedings

Volumn 75, Issue 7, 2000, Pages 733-739

  Kumar, K Shiva ^a   Malet, Peter F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PORTAL HYPERTENSION; PREVALENCE; REVIEW; WEIGHT REDUCTION;

EID: 0033938544     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64621-1     Document Type: Review

References (38)

1. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434-438.
2. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis [published erratum appears in Ann Intern Med. 1997;127:658]. Ann Intern Med. 1997;126:137-145.
3. Nasrallah SM, Wills CE Jr, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci. 1981;26:325-327.
4. Andersen T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes. 1984;8:97-106.
5. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106-1110.
6. Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 1987;82:650-654.
7. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988;95:1056-1062.
8. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol. 1989;20:594-598.
9. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74-80.
10. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994;107:1103-1109.
11. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology. 1996;23:1464-1467.
12. Pinto HC, Baptista A, Camilo ME, Valente A, Saragoca A, de Moura MC. Nonalcoholic steatohepatitis: clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci. 1996;41:172-179.
13. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356-1362.
14. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr. 1994;125:239-241.
15. Kral JG, Schaffner F, Pierson RN Jr, Wang J. Body fat topography as an independent predictor of fatty liver. Metabolism. 1993;42:548-551.
16. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr. 1995;127:700-704.
17. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984;3:408-414.
18. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30:48-53.
19. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E [abstract]. Gastroenterology. 1998;114:A1284-A1285. Abstract L0356.
20. Day CP, James OFW. Steatohepatitis: a tale of two "hits"? [editorial]. Gastroenterology. 1998;114:842-845.
21. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology. 1996;23:155-163.
22. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998;27:128-133.
23. McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis. 1993;13:170-182.
24. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 1997;94:2557-2562.
25. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450-455.
26. Tankurt E, Biberoglu S, Ellidokuz E, et al. Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis [letter]. J Hepatol. 1999;31:963.
27. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 1995;96:2461-2468.
28. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311-318.
29. Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol. 1999;31: 421-429.
30. Smith BC, Gorve J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology. 1998;27:1695-1699.
31. Younossi ZM, Gramlich T, Bacon BR, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology. 1999;30:847-850.
32. Oelsner DH, Caldwell SH, Hespenheide EE, Driscoll CJ. Cryptogenic cirrhosis: a disease largely of mild to moderately obese, mildly diabetic older females [abstract]. Hepatology. 1997;26(program issue):357A. Abstract 914.
33. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. 1986;220:83-88.
34. Basaranoglu M, Sonsuz A, Bilir M, et al. A controlled trial of gemfibrozil in the treatment of nonalcoholic steatohepatitis [abstract]. Hepatology. 1998;28(suppl):166A. Abstract 15.
35. Desai TK, Chiorean M. Phlebotomy reduces transaminase levels in patients with chronic non-alcoholic steatohepatitis [abstract]. Gastroenterology. 1998;114:A1233. Abstract L0141.
36. Requarth JA, Burchard KW, Colacchio TA, et al. Long-term morbidity following jejunoileal bypass: the continuing potential need for surgical reversal. Arch Surg. 1995;130:318-325.
37. Kim WR, Poterucha JJ, Porayko MK, Dickson ER, Steers JL, Wiesner RH. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation. 1996;62:1802-1805.
38. Weston S, Charlton MR, Lindor KD. Liver transplantation for nonalcoholic steatohepatitis [abstract]. Gastroenterology. 1998;114:A1364. Abstract L0681.